Principia Biopharma Inc. Insider Trading for November 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Principia Biopharma Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Principia Biopharma Inc. for November 2019.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 08 2019 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Option Exercise | M | 3.00 | 1,075 | 3,223 | 14,447 | |
Nov 08 2019 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Option Exercise | M | 3.00 | 1,075 | 3,223 | 14,447 | |
Nov 08 2019 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Option Exercise | M | 1.91 | 1,651 | 3,149 | 0 | |
Nov 08 2019 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Option Exercise | M | 1.91 | 1,651 | 3,149 | 0 | |
Nov 08 2019 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Option Exercise | M | 1.91 | 6,147 | 11,726 | 0 | |
Nov 08 2019 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Option Exercise | M | 1.91 | 6,147 | 11,726 | 0 | |
Nov 08 2019 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Option Exercise | M | 0.64 | 1,127 | 717 | 0 | |
Nov 08 2019 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Option Exercise | M | 0.64 | 1,127 | 717 | 0 | |
Nov 08 2019 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Sell | S | 32.39 | 10,000 | 323,914 | 29,819 | 39.8 K to 29.8 K (-25.11 %) |
Nov 08 2019 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Sell | S | 32.39 | 10,000 | 323,914 | 29,819 | 39.8 K to 29.8 K (-25.11 %) |
Nov 08 2019 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Buy | M | 3.00 | 1,075 | 3,223 | 39,819 | 38.7 K to 39.8 K (+2.77 %) |
Nov 08 2019 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Buy | M | 3.00 | 1,075 | 3,223 | 39,819 | 38.7 K to 39.8 K (+2.77 %) |
Nov 08 2019 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Buy | M | 1.91 | 1,651 | 3,149 | 38,744 | 37.1 K to 38.7 K (+4.45 %) |
Nov 08 2019 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Buy | M | 1.91 | 1,651 | 3,149 | 38,744 | 37.1 K to 38.7 K (+4.45 %) |
Nov 08 2019 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Buy | M | 1.91 | 6,147 | 11,726 | 37,093 | 30.9 K to 37.1 K (+19.86 %) |
Nov 08 2019 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Buy | M | 1.91 | 6,147 | 11,726 | 37,093 | 30.9 K to 37.1 K (+19.86 %) |
Nov 08 2019 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Buy | M | 0.64 | 1,127 | 717 | 30,946 | 29.8 K to 30.9 K (+3.78 %) |
Nov 08 2019 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Buy | M | 0.64 | 1,127 | 717 | 30,946 | 29.8 K to 30.9 K (+3.78 %) |